• 1
    Annual Report of the New Hampshire Department of Health and Human Services, Concord, NH. New Hampshire State Cancer Registry, 1993.
  • 2
    Chen VW, Wu XC. Cancer in North America, 1990–1994. Volume II: Mortality. Sacramento, CA: North American Association of Central Cancer Registries, 1998.
  • 3
    Tabar L, Vitak B, Chen HT, Yen MF, Duffy SW, Smith RA. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality. Cancer. 2001; 91: 17241731.
  • 4
    Breen N, Kessler L. Trends in cancer screening: United States, 1987 and 1992. Oncology. 1996; 10: 328330.
  • 5
    Urban N, Taplin SH, Taylor VM, Peacock S, Anderson G, Conrad D. Community organization to promote breast cancer screening among women ages 50–75. Prev Med. 1995; 24: 477484.
  • 6
    Meissner HI, Breen N, Coyne C, Legler JM, Green DT, Edwards BK. Breast and cervical cancer screening interventions: an assessment of the literature. Cancer Epidemiol Biomarkers Prev. 1998; 7: 951961.
  • 7
    Anonymous. Self-reported use of mammography among women aged ≥ 40 years, United States, 1989–1995. MMWR. 1997; 46: 937941.
  • 8
    Dolan NC, Reifler DR, McGrae, McDermott, McGaghie WC. Adherence to screening mammography recommendations in a university general medicine clinic. J Gen Intern Med. 1995; 10: 299306.
  • 9
    Zapka JG, Stoddard A, Maul L, Costanza ME. Interval adherence to mammography screening guidelines. Med Care. 1991; 2: 697707.
  • 10
    Rimer BK, Trock B, Engstrom PF, Lerman, C, King E. Why do some women get regular mammograms. Am J Prev Med. 1991; 7: 6974.
  • 11
    Mayer JA, Slymen DJ, Jones JA, et al. Mammography knowledge and intentions among insured women. Prev Med. 1992; 21: 817.
  • 12
    Lerman C, Rimer, B, Trock, B, Balshem A, Engstrom PF. Factors associated with repeat adherence to breast cancer screening. Prev Med. 1990; 19: 279290.
  • 13
    Chrvala C. Breast cancer risk status as a predictor for breast cancer screening behaviors. Prog Clin Biol Res. 1990; 339: 239251.
  • 14
    Lerman C, Daly M, Sands C, et al. Mammography adherence and psychological distress among women at risk for breast cancer. J Natl Cancer Inst. 1993; 85: 10741080.
  • 15
    RiesLAG, MillerBA, HankeyBF, editors. SEER cancer statistics review, 1973–1991. Bethesda: National Cancer Institute, 1994.
  • 16
    Colditz GA, Wiett WC, Hunter DJ. Family history age and risk of breast cancer. JAMA. 1993; 270: 338343.
  • 17
    London SJ, Connolly JL, Schnitt SJ. A prospective study of benign breast disease and the risk of breast cancer. JAMA. 1992; 267: 941944.
  • 18
    Bodian CA. Benign breast diseases, carcinoma in situ, and breast cancer risk. Epidemiol Rev. 1993; 15: 177187.
  • 19
    Harris JR, Lippman ME, Veronesi U. Breast cancer. N Engl J Med. 1992; 327: 319327.
  • 20
    Laya MB, Gallagher JC, Schreiman JA. Effect of postmenopausal hormone replacement therapy on mammographic density and parenchymal pattern. Radiology. 1995; 196: 443437.
  • 21
    Stomper PC, Van Voorhis BJ, Ravkinar VA. Mammographic changes associated with postmenopausal hormone replacement therapy: a longitudinal study. Radiology. 1990; 174: 487490.
  • 22
    Leung W, Goldberg F, Zee B, Sterns E. Mammographic density in women on postmenopausal hormone replacement therapy. Surgery. 1997; 122: 669674.
  • 23
    Kelsey JL, Gammon MD. Epidemiology of breast cancer. Epidemiol Rev. 1990; 12: 228240.
  • 24
    Grady D, Rubin SM, Petitti DB. Hormone therapy to prevent disease and prolong life in post-menopausal women. Ann Intern Med. 1992; 117: 10161037.
  • 25
    Boyd NF, Byng JW, Jong RA, Fishell EK, Little LE, Miller AB. Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst. 1995; 87: 670675.
  • 26
    McCarthy EP, Burns RB, Freund KM, et al. Mammography use, breast cancer stage at diagnosis, and survival among older women. J Am Geriatr Soc. 2000; 48: 12261233.
  • 27
    Tabar L, Vitak B, Chen HH, et al. The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up. Radiol Clin North Am. 2000; 38: 625651.
  • 28
    Carney PA, Poplack SP, Wells WA, Littenberg B. Development and design of a population-based mammography registry: the New Hampshire Mammography Network. AJR Am J Roentgenol. 1996; 167: 367372.
  • 29
    D'Orsi CJ, Bassett LW, Feig SA, et al. Breast imaging reporting and data system. 3rd ed. Reston, Va: American College of Radiology, 1998.
  • 30
    Black WC, Nease RF Jr., Tosteson AN. Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age. J Natl Cancer Inst. 1995; 87: 720731.
  • 31
    Woloshin S, Schwartz LM, Byram S, Fishhoff B, Welch H. A new scale for assessing perceptions of chance: a validation study. Med Decis Making. 2000; 20: 298307.
  • 32
    Speilberger CD, Gorsuch RL, Lushene RE. Manual for the State Trait Anxiety Inventory (Self©Evaluation Questionnaire). Palo Alto, Ca: Consulting Psychologists Press, 1970.
  • 33
    Champion V. Development of a benefits and barriers scale for mammography utilization. Cancer Nurs. 1995; 18: 5359.
  • 34
    Schottenfield D, Kerner J. Final Report© Cancer Control Development Grant (National Cancer Institute grant- CA-16402). Bethesda: National Cancer Institute, 1984.
  • 35
    Kash KM, Holland JC, Osborne MP, Miller DG. Psychological counseling strategies for women at risk of breast cancer. J Natl Cancer Inst Monogr. 1995; 17: 7379.